Jim Cramer says the markets are optimistic about a vaccine, but he cautions there’s a long way to go. We still need more stimulus.

Jim Cramer says science and technology are responsible for this market strength and we might be seeing the end of the healthcare recession.

Not so fast, says Jim Cramer. Investors need to remember things will never be the same. He looks for stocks with real potential.

New record highs for the indexes? Jim Cramer says we've crushed five of the biggest obstacles in the way of this quiet but strong bull market.

Jim Cramer takes a look at LendingTree, Scorpio Tankers, Okta, SunPower, Oneok, Plains All American Pipeline, HubSpot, ZScaler.

Now's the tough part: Figuring out when we go back down.

'Blind side' competition is playing havoc with some highly visible companies, says Jim Cramer. You can't compete with free.

Jim Cramer's bullish on Alexion Pharmaceuticals and Incyte. But, he says, Disney's good for the long term.

Jim Cramer says he likes LUV and UAL, but JBLU is not a favorite.

The troubled retailer has taken another major step to try to stave off closure.

“2022 was a strong year for AMD as we delivered best-in-class growth and record revenue despite the weak PC environment in the second half of the year," said CEO Lisa Su

Wall Street extended the S&P 500's solid January gains Tuesday as investors sorted through a wave of corporate earnings ahead of tomorrow's crucial Fed rate decision.